A collaborative study with Harvard Medical School
Introducing an Innovative Bioactive Microfibre Gelling (BMG™) Technology Across an Acute Vascular Service: The Clinical and Patient Benefits
Publication Details:
Ramoutar, V., Rillera, R. & Rinosh, B. (2023) Introducing an innovative Bioactive Microfibre Gelling (BMG™) technology across an acute vascular service: The clinical and patient benefits. Wound Care Today.
Wound Details
Patient Group: 7 patients with acute vascular wounds
Key Findings and Data:
- MaxioCel dressing significantly controlled wound exudate, improving peri-wound skin condition.
- Patient reported reduction in wound pain, perception reducing from 8 to 2 (VAS)
- Noticeable improvement in wound debridement after just a few dressing changes.
- Wound area and depth reduction observed over 4 weeks.
Dressing effectively controlled minor bleeding in vascular wounds.
Key Insights
- MaxioCel® combined multiple dressing benefits in one, simplifying application and removal while being well-accepted by clinicians and patients.
- MaxioCel’s ability to optimize healing and exudate control could contribute to earlier discharge and reduced hospital stays.
Related Publications
Evaluation of a 100% Chitosan Dressing in the Treatment of Diabetic Foot Ulcers
Chronic Wound Debridement in an Acute Setting
Severe Pressure Ulcer Debridement in the Acute Sector
A Multi-disciplinary Team Approach to the Management
